CLOV vs LUNG
Clover Health Investments Corp (CLOV) versus Pulmonx Corp (LUNG) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported LUNG revenue for 2024-12-31 was $83.8M. Net income was -$56.4M. Revenue was up 22.0% from 2023-12-31 to 2024-12-31. LUNG currently screens at market cap $111.9M.
CLOV currently screens at market cap $1.55B. LUNG currently screens at market cap $111.9M.
Not investment advice. Open the CLOV and LUNG stock pages for the full models.
Not investment advice.